Is The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature | Zendy

Mustafa Aras | Zendy; Fuat Dede | Zendy; Trevor Jones | Zendy; Sabahat İnanır | Zendy; Tanju Yusuf Erdıl | Zendy; Halil Turgut Turoğlu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is The Value of FDG PET/CT in Evaluating Renal Metastasis Underestimated? A Case Report and Review of The Literature

Author(s) -

Mustafa Aras,

Fuat Dede,

Trevor Jones,

Sabahat İnanır,

Tanju Yusuf Erdıl,

Halil Turgut Turoğlu

Publication year - 2013

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.130

Subject(s) - medicine , radiology , pet ct , metastasis , urinary system , lung cancer , kidney , nuclear medicine , lung , gold standard (test) , cancer , computed tomography , pathology

Contrast-enhanced CT or MRI are used as a gold standard imaging modalities in the detection and characterization of renal masses. On the other hand, the role of FDG PET/CT in evaluating primary or metastatic cancers of the kidney is limited due to the excretion of FDG through urinary tract. We reported the FDG PET/CT of a lung cancer patient with multiple metastases in both kidneys which were missed in previous PET/CT, and underestimated on sequential diagnostic abdominal CT study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research